Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass

Blood lactate and blood pressure measurements are important predictors of life-threatening complications after infant open-heart surgeries requiring cardiopulmonary bypass (CPB). We have developed an intravascular nitric oxide (NO)-releasing 5-Fr catheter that contains a lactate sensor for continuou...

Full description

Bibliographic Details
Main Authors: Kenneth Kwun Yin Ho, Yun-Wen Peng, Minyi Ye, Lise Tchouta, Bailey Schneider, McKenzie Hayes, John Toomasian, Marie Cornell, Alvaro Rojas-Pena, John Charpie, Hao Chen
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Chemosensors
Subjects:
Online Access:https://www.mdpi.com/2227-9040/8/3/56
_version_ 1797562086767722496
author Kenneth Kwun Yin Ho
Yun-Wen Peng
Minyi Ye
Lise Tchouta
Bailey Schneider
McKenzie Hayes
John Toomasian
Marie Cornell
Alvaro Rojas-Pena
John Charpie
Hao Chen
author_facet Kenneth Kwun Yin Ho
Yun-Wen Peng
Minyi Ye
Lise Tchouta
Bailey Schneider
McKenzie Hayes
John Toomasian
Marie Cornell
Alvaro Rojas-Pena
John Charpie
Hao Chen
author_sort Kenneth Kwun Yin Ho
collection DOAJ
description Blood lactate and blood pressure measurements are important predictors of life-threatening complications after infant open-heart surgeries requiring cardiopulmonary bypass (CPB). We have developed an intravascular nitric oxide (NO)-releasing 5-Fr catheter that contains a lactate sensor for continuous in-blood lactate monitoring and a dedicated lumen for third-party pressure sensor attachment. This device has antimicrobial and antithrombotic properties and can be implanted intravascularly. The importance of this design is its ability to inhibit thrombosis, due to the slow release of NO through the surface of the catheter and around the electrochemical lactate sensors, to allow continuous data acquisition for more than 48 h. An in vivo study was performed using six piglets undergoing open-heart surgery with CPB and cardioplegic arrest, in order to mimic intra-operative conditions for infants undergoing cardiac surgery with CPB. In each study of 3 h, two 5-Fr NO-releasing lactate and blood-pressure monitoring catheters were implanted in the femoral vessels (arteries and veins) and the CPB circuitry to monitor changing lactate levels and blood pressures during and immediately after aortic cross-clamp removal and separation from CBP. Electrical signals continuously acquired through the sensors were processed and displayed on the device’s display and via Bluetooth to a computer in real-time with the use of a two-point in vivo calibration against blood gas results. The study results show that lactate levels measured from those sensors implanted in the CPB circuit during CPB were comparable to those acquired by arterial blood gas measurements, whereas lactate levels measured from sensors implanted in the femoral artery were closely correlated with those acquired intermittently by blood gas prior to CPB initiation, but not during CPB. Blood pressure sensors attached to one lumen of the device displayed accurate blood pressure readings compared to those measured using an FDA approved pressure sensor already on the market. We recommend that the sensor be implanted in the CPB’s circuit to continuously monitor lactate during CPB, and implanted in the femoral arteries or jugular veins to monitor lactate before and after CPB. Blood pressures dramatically drop during CPB due to lower blood flow into the lower body, and we suspect that the femoral arteries are likely collapsing or constricting on the implanted catheter and disrupting the sensor-to-blood contact. This study shows that the device is able to accurately and continuously monitor lactate levels during CPB and potentially prevent post-surgery complications in infants.
first_indexed 2024-03-10T18:24:37Z
format Article
id doaj.art-4ff390a1003a455c98c8bfc39066ac24
institution Directory Open Access Journal
issn 2227-9040
language English
last_indexed 2024-03-10T18:24:37Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Chemosensors
spelling doaj.art-4ff390a1003a455c98c8bfc39066ac242023-11-20T07:08:03ZengMDPI AGChemosensors2227-90402020-07-01835610.3390/chemosensors8030056Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary BypassKenneth Kwun Yin Ho0Yun-Wen Peng1Minyi Ye2Lise Tchouta3Bailey Schneider4McKenzie Hayes5John Toomasian6Marie Cornell7Alvaro Rojas-Pena8John Charpie9Hao Chen10Biocrede Inc., Plymouth, MI 48170, USADivision of Pediatric Cardiology, Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USABiocrede Inc., Plymouth, MI 48170, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USAExtracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USADivision of Pediatric Cardiology, Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USABiocrede Inc., Plymouth, MI 48170, USABlood lactate and blood pressure measurements are important predictors of life-threatening complications after infant open-heart surgeries requiring cardiopulmonary bypass (CPB). We have developed an intravascular nitric oxide (NO)-releasing 5-Fr catheter that contains a lactate sensor for continuous in-blood lactate monitoring and a dedicated lumen for third-party pressure sensor attachment. This device has antimicrobial and antithrombotic properties and can be implanted intravascularly. The importance of this design is its ability to inhibit thrombosis, due to the slow release of NO through the surface of the catheter and around the electrochemical lactate sensors, to allow continuous data acquisition for more than 48 h. An in vivo study was performed using six piglets undergoing open-heart surgery with CPB and cardioplegic arrest, in order to mimic intra-operative conditions for infants undergoing cardiac surgery with CPB. In each study of 3 h, two 5-Fr NO-releasing lactate and blood-pressure monitoring catheters were implanted in the femoral vessels (arteries and veins) and the CPB circuitry to monitor changing lactate levels and blood pressures during and immediately after aortic cross-clamp removal and separation from CBP. Electrical signals continuously acquired through the sensors were processed and displayed on the device’s display and via Bluetooth to a computer in real-time with the use of a two-point in vivo calibration against blood gas results. The study results show that lactate levels measured from those sensors implanted in the CPB circuit during CPB were comparable to those acquired by arterial blood gas measurements, whereas lactate levels measured from sensors implanted in the femoral artery were closely correlated with those acquired intermittently by blood gas prior to CPB initiation, but not during CPB. Blood pressure sensors attached to one lumen of the device displayed accurate blood pressure readings compared to those measured using an FDA approved pressure sensor already on the market. We recommend that the sensor be implanted in the CPB’s circuit to continuously monitor lactate during CPB, and implanted in the femoral arteries or jugular veins to monitor lactate before and after CPB. Blood pressures dramatically drop during CPB due to lower blood flow into the lower body, and we suspect that the femoral arteries are likely collapsing or constricting on the implanted catheter and disrupting the sensor-to-blood contact. This study shows that the device is able to accurately and continuously monitor lactate levels during CPB and potentially prevent post-surgery complications in infants.https://www.mdpi.com/2227-9040/8/3/56blood lactatecontinuous monitoringlactate sensorscongenital heart diseasecardiopulmonary bypasscardioplegic ischemia
spellingShingle Kenneth Kwun Yin Ho
Yun-Wen Peng
Minyi Ye
Lise Tchouta
Bailey Schneider
McKenzie Hayes
John Toomasian
Marie Cornell
Alvaro Rojas-Pena
John Charpie
Hao Chen
Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
Chemosensors
blood lactate
continuous monitoring
lactate sensors
congenital heart disease
cardiopulmonary bypass
cardioplegic ischemia
title Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
title_full Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
title_fullStr Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
title_full_unstemmed Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
title_short Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass
title_sort evaluation of an anti thrombotic continuous lactate and blood pressure monitoring catheter in an in vivo piglet model undergoing open heart surgery with cardiopulmonary bypass
topic blood lactate
continuous monitoring
lactate sensors
congenital heart disease
cardiopulmonary bypass
cardioplegic ischemia
url https://www.mdpi.com/2227-9040/8/3/56
work_keys_str_mv AT kennethkwunyinho evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT yunwenpeng evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT minyiye evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT lisetchouta evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT baileyschneider evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT mckenziehayes evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT johntoomasian evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT mariecornell evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT alvarorojaspena evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT johncharpie evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass
AT haochen evaluationofanantithromboticcontinuouslactateandbloodpressuremonitoringcatheterinaninvivopigletmodelundergoingopenheartsurgerywithcardiopulmonarybypass